News Takeda Pharmaceutical Company Limited BOERSE MUENCHEN

Equities

TKDA

US8740602052

Real-time BOERSE MUENCHEN Other stock markets 03:14:02 2024-07-10 am EDT			5-day change	1st Jan Change
12.1 ^EUR	0.00%		0.00%	-6.20%

Jul. 09	Takeda Issues New Shares, Disposes of Treasury Shares Under Incentive Scheme	MT
Jul. 03	Blackstone selling Japan drugmaker Alinamin to MBK Partners	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Takeda Issues New Shares, Disposes of Treasury Shares Under Incentive Scheme	Jul. 09	MT
China's Supreme People's Court Clarifies Priority Examination Standard in Recent Ruling	Jul. 05	AQ
China's SPC Clarifies Priority Examination Standard In Recent Ruling	Jul. 05	AQ
Blackstone selling Japan drugmaker Alinamin to MBK Partners	Jul. 02	RE
Koru Medical Systems' FreedomEdge System Receives Regulatory Approval in Japan	Jul. 02	MT
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan	Jul. 02	CI
Codexis Sells Fabry, Pompe Disease Compounds to Crosswalk Therapeutics	Jul. 01	MT
Corza Medical Inc. completed the acquisition of TachoSil manufacturing operations in Linz, Austria. from Takeda Pharmaceutical Company Limited.	Jun. 30	CI
Takeda Pharmaceutical : Annual Securities Report (Part 1. Information on Takeda, IV. Information on the Company, 4. Corporate Governance)	Jun. 28	PU
Takeda Announces the Publication of its Annual Report on Form 20-F for FY2023	Jun. 27	AQ
TAKEDA PHARMACEUTICAL : Form 6 K	Jun. 26	PU
Takeda Pharmaceutical : Announces New Assignments of Directors Form 6 K	Jun. 26	PU
Takeda Announces New Assignments of Directors	Jun. 26	BU
Transcript : Takeda Pharmaceutical Company Limited - Shareholder/Analyst Call	Jun. 25
US CDC alerts healthcare providers of increase in dengue cases	Jun. 25	RE
Takeda's Cancer Drug Gets European Commission Approval	Jun. 25	MT
Hutchmed China notes Takeda obtains EU approval for Fruzaqla	Jun. 24	AN
Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators	Jun. 24	MT
Hutchmed (China), Takeda Secure EU Approval for Colorectal Cancer Treatment	Jun. 24	MT
Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies	Jun. 24	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Takeda Pharmaceutical Company Limited BOERSE MUENCHEN

Equities

TKDA

US8740602052

Summary

Filters